Imaging of neuroinflammation

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 12, 2011, Pages 2198-2201

  Ciarmiello, Andrea ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMYLOID; AMYLOID BETA PROTEIN; CARRIER PROTEIN; CHEMOKINE RECEPTOR CX3CR1; FLUORODEOXYGLUCOSE F 18; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11;

ALZHEIMER DISEASE; ASTROCYTOSIS; BRAIN ATROPHY; BRAIN BLOOD FLOW; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; HUMAN; INNATE IMMUNITY; MICROGLIA; MOLECULAR IMAGING; NEUROIMAGING; NONHUMAN; NOTE; POSITRON EMISSION TOMOGRAPHY; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION;

BRAIN; ENCEPHALITIS; HUMANS; IMMUNOLOGIC FACTORS; MOLECULAR IMAGING; NEURODEGENERATIVE DISEASES; RADIONUCLIDE IMAGING;

EID: 84856214011     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1959-x     Document Type: Note

References (37)

1. Santillo AF, Gambini JP, Lannfelt L, Långström B, Ulla-Marja L, Kilander L, et al. In vivo imaging of astrocytosis in Alzheimer's disease: an (11) C-L-deuteriodeprenyl and PIB PET study. Eur J Nucl Med Mol Imaging 2011. doi:10.1007/s00259-011-1895-9.
2. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009;32:638-47. doi:10.1016/j.tins.2009.08.002.
3. Lansbury PT, Lashuel HA. A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 2006;443:774-9. doi:10.1038/ nature05290. (Pubitemid 44622681)
4. Barres BA. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 2008;60:430-40. doi:10.1016/j. neuron. 2008.10.013.
5. Jamin N, Neumann JM, Ostuni MA, Vu TK, Yao ZX, Murail S, et al. Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol Endocrinol 2005;19:588-94. doi:10.1210/me.2004-0308. (Pubitemid 40349433)
6. Lacapère JJ, Papadopoulos V. Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids 2003;68:569-85. (Pubitemid 37075920)
7. Sutter AP, Maaser K, Höpfner M, Barthel B, Grabowski P, Faiss S, et al. Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cells. Int J Cancer 2002;102:318-27. doi:10.1002/ijc.10724. (Pubitemid 35265870)
8. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, et al. In-vivo measurement of activated microglia in dementia. Lancet 2001;358:461-7. doi:10.1016/S0140-6736(01) 05625-2. (Pubitemid 32769854)
9. Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, Syrota A, et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology 2000;55:1052-4.
10. Banati RB, Cagnin A, Brooks DJ, Gunn RN, Myers R, Jones T, et al. Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury. Neuroreport 2001;12:3439-42. (Pubitemid 33065473)
11. Junck L, Olson JM, Ciliax BJ, Koeppe RA, Watkins GL, Jewett DM, et al. PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol 1989;26:752-8. doi:10.1002/ana.410260611. (Pubitemid 20011009)
12. Goerres GW, Revesz T, Duncan J, Banati RB. Imaging cerebral vasculitis in refractory epilepsy using [(11) C] (R)-PK11195 positron emission tomography. AJR Am J Roentgenol 2001;176:1016-8. (Pubitemid 32240956)
13. Politis M, Pavese N, Tai YF, Kiferle L, Mason SL, Brooks DJ, et al. Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study. Hum Brain Mapp 2011;32:258-70. doi:10.1002/hbm.21008.
14. Cagnin A, Rossor M, Sampson EL, Mackinnon T, Banati RB. In vivo detection of microglial activation in frontotemporal dementia. Ann Neurol 2004;56:894-7. doi:10.1002/ana.20332. (Pubitemid 39578457)
15. Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA, et al. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 2006;66:1638-43. doi:10.1212/01.wnl.0000222734.56412. 17. (Pubitemid 43964614)
16. Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J Nucl Med 2006;47:215-22. (Pubitemid 46780885)
17. Squitieri F, Cannella M, Simonelli M, Sassone J, Martino T, Venditti E, et al. Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease. CNS Neurosci Ther 2009;15:1-11. doi:10.1111/j.1755-5949.2008.00068.x.
18. Takano A, Gulyás B, Varrone A, Karlsson P, Sjoholm N, Larsson S, et al. Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [(18) F]FEDAA1106: a human whole-body PET study. Eur J Nucl Med Mol Imaging 2011. doi:10.1007/s00259-011-1864-3.
19. Youdim MB, Bakhle YS. Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. Br J Pharmacol 2006;147 Suppl 1:S287-96. doi:10.1038/sj.bjp. 0706464. (Pubitemid 43077287)
20. Saura J, Andrés N, Andrade C, Ojuel J, Eriksson K, Mahy N. Biphasic and region-specific MAO-B response to aging in normal human brain. Neurobiol Aging 1997;18:497-507. (Pubitemid 27497146)
21. Jossan SS, Gillberg PG, Gottfries CG, Karlsson I, Oreland L. Monoamine oxidase B in brains from patients with Alzheimer's disease: a biochemical and autoradiographical study. Neuroscience 1991;45:1-12.
22. Mann JJ, Kaplan RD, Bird ED. Elevated postmortem monoamine oxidase B activity in the caudate nucleus in Huntington's disease compared to schizophrenics and controls. J Neural Transm 1986;65:277-83. (Pubitemid 16073149)
23. Ekblom J, Jossan SS, Oreland L, Walum E, Aquilonius SM. Reactive gliosis and monoamine oxidase B. J Neural Transm Suppl 1994;41:253-8. (Pubitemid 24215699)
24. Ekblom J, Jossan SS, Bergström M, Oreland L, Walum E, Aquilonius SM. Monoamine oxidase-B in astrocytes. Glia 1993;8:122-32. doi:10.1002/glia. 440080208.
25. Fowler JS, MacGregor RR, Wolf AP, Arnett CD, Dewey SL, Schlyer D, et al. Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. Science 1987;235:481-5. (Pubitemid 17009586)
26. Johansson A, Engler H, Blomquist G, Scott B, Wall A, Aquilonius SM, et al. Evidence for astrocytosis in ALS demonstrated by [11C] (L)-deprenyl-D2 PET. J Neurol Sci 2007;255:17-22. doi:10.1016/j.jns.2007.01.057. (Pubitemid 46415796)
27. Engler H, Lundberg PO, Ekbom K, Nennesmo I, Nilsson A, Bergström M, et al. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease. Eur J Nucl Med Mol Imaging 2003;30:85-95. doi:10.1007/s00259-002-1008- x. (Pubitemid 36692897)
28. McGeer PL, Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 1992;42:447-9.
29. Kim TS, Lim HK, Lee JY, Kim DJ, Park S, Lee C, et al. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2008;436:196-200. doi:10.1016/j.neulet. 2008.03.019.
30. Liu Z, Condello C, Schain A, Harb R, Grutzendler J. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-beta phagocytosis. J Neurosci 2010;30:17091-101. doi:10.1523/JNEUROSCI.4403-10.2010.
31. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, et al. Imaging beta-amyloid burden in aging and dementia. Neurology 2007;68:1718-25. doi:10.1212/01.wnl.0000261919.22630.ea. (Pubitemid 46763260)
32. Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, Gong SJ, et al. Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease. J Nucl Med 2007;48:547-52. (Pubitemid 47571408)
33. Yen CK, Yano Y, Budinger TF, Friedland RP, Derenzo SE, Huesman RH, et al. Brain tumor evaluation using Rb-82 and positron emission tomography. J Nucl Med 1982;23:532-7. (Pubitemid 12070817)
34. Iannotti F, Fieschi C, Alfano B, Picozzi P, Mansi L, Pozzilli C, et al. Simplified, noninvasive PET measurement of blood-brain barrier permeability. J Comput Assist Tomogr 1987;11:390-7. (Pubitemid 17081502)
35. Pozzilli C, Bernardi S, Mansi L, Picozzi P, Iannotti F, Alfano B, et al. Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography. J Neurol Neurosurg Psychiatry 1988;51:1058-62.
36. Carrió I. Key role of nuclear medicine in bringing imaging biomarkers into clinical practice. Eur J Nucl Med Mol Imaging 2009;36:1937-9. doi:10.1007/s00259-009-1318-3.
37. Stenström A, Arai Y, Oreland L. Intra-and extraneuronal monoamineoxidase-A and-B activities after central axotomy (hemisection) on rats. J Neural Transm 1985;61:105-13. (Pubitemid 15133087)